Spain: Software in the light of the new Spanish patent law

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Spain: Software in the light of the new Spanish patent law

Much water has flowed under the bridge since 1986, yet the law regulating the patentability of software remains the same. A close look at the new guidelines for examination in the Spanish Patent and Trade Mark Office (OEPM) shows that those aspects concerning patentability remain the same as in the original Guidelines … so we may give it a big yes, nothing has changed.

At the OEPM, formal and technical examinations are carried out at the same time; so, on the one hand computer programs may be a form of computer-implemented inventions while, on the other hand, computer programs are included in the list of exclusions.

In the light of new Spanish patent law, computer programs are still excluded but as for the other elements of that list, the scope of exclusion is limited; that is, only the exclusion of the invention applies insofar as the object for protection as claimed comprises one of said inventions as such. Thus, the Spanish law expressly allows methods to be carried by a programmable devices or systems as long as the computer program is capable of producing, when running in the corresponding programmable device or system, a further technical effect that goes beyond those normal physical effects implicit to the device or system themselves; this is the so called further technical effect we may find in the guidelines for examination in the European Patent Office on GII, 3.6.

Nonetheless, we may still find claims comprising both technical and no technical features. In this regard the new guidelines for examination in the OEPM state that the implementation of an invention, considered for other reasons not intrinsically patentable, using physical elements or technical means, does not alter the essence of the invention. Hence, the mere use of technical means for the implementation of an excluded invention from patentability does not necessarily give the essential technical nature which averts that exclusion.

Since the nature of the invention in view of the exclusions to patentability is examined at the same time as the formal examination is carried out, we are not going to receive a search report with a written opinion regarding those aspects that are deemed to be an invention.

This is still a problem with the new law and the corresponding guidelines for examination in Spain: claims comprising technical and non-technical features (mixed claims) may not pass the first filter at the OEPM.

robledo.jpg

Ignacio Robledo


PONS IPGlorieta Rubén Darío, 428010 – Madrid SpainTel: +34 917007600Fax: +34 913086103clientes@pons.eswww.ponsip.com

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article